Overview / Abstract: |
Target Audience Activity Overview As the role of primary care clinicians in a variety of disease states continues to evolve and expand, it is vital that they stay up-to-date on education surrounding current trends in the area. This half-day virtual summit with expert faculty is the ideal platform to close knowledge gaps in a variety of respiratory diseases for the primary care clinician. The activity will provide information on risk factors in pulmonary diseases, diagnostic criteria for rare respiratory diseases, and available and emerging treatment options to manage those diseases. This educational activity is an archive of a live virtual symposium held on October 31, 2020. Learning Objectives Assess risk factors for pulmonary diseases and describe the diagnostic process |
Expiration |
Nov 17, 2021 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
4 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Steven D. Nathan, MD, FCCP |
Sponsors / Supporters / Grant Providers |
Bellerophon Therapeutics, Gilead Sciences, Regeneron Pharmaceuticals, Roche, United Therapeutics, Gossamer Bio, Reata Pharmaceuticals, Viela Bio, Genentech, Phillips, Janssen, Sanofi/Regeneron, Actelion, Bayer, Roche, Third Pole Therapeutics, Actelion |
Keywords / Search Terms |
Relias LLC relias, free CME Free CE CME |